CIVILICA We Respect the Science
(ناشر تخصصی کنفرانسهای کشور / شماره مجوز انتشارات از وزارت فرهنگ و ارشاد اسلامی: ۸۹۷۱)

Evaluation of an Immunomodulator Drug as a Radioprotectant on Human Peripheral Blood Lymphocytes In Vitro

عنوان مقاله: Evaluation of an Immunomodulator Drug as a Radioprotectant on Human Peripheral Blood Lymphocytes In Vitro
شناسه ملی مقاله: JR_MISJ-9-1_006
منتشر شده در در سال 1397
مشخصات نویسندگان مقاله:

Zahra Sattarpour - Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Bahzad Baradaran - Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Alireza Farajollahi - Department of Medical Physics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Mohammad Asghari Jafarabadi - Department of Statistics and Epidemiology, Faculty of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran
Vahid Khazeh - Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Jalil Pirayesh Islamian - Department of Medical Physics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

خلاصه مقاله:
Background: IMOD™, a selenium enriched extract of the plants Tanacetum vulgare, Urtica dioica, and Rosa canina, has an excellent effect on oxidative stress. In this study, we investigated the radioprotective effects of this immunomodulatory drug on human peripheral blood lymphocytes.Methods: Peripheral blood samples obtained from venipuncture of the brachial vein were treated with IMOD™ (۵, ۱۰, ۱۵, ۲۰ μl) for ۳۰ min and Cobalt ۶۰ γ-rays (۰.۲۵, ۰.۵, ۱, ۲ Gy) as the test groups and cultured with the control. We used the micronuclei assay, cell death detection, and cell toxicity assay to analyze the treatment effects.Results: The frequency of micronuclei were ۱.۶۶ (۰ Gy), ۵.۳۳ (۰.۲۵ Gy), ۹.۶۷ (۰.۵ Gy), ۱۷.۶۷ (۱ Gy), and ۲۳.۶۷ (۲ Gy) in the irradiated lymphocytes (P<۰.۰۰۱). The percentage of micronuclei frequency reduced to ۲۰%, ۲۶.۸۳%, ۳۷.۶۸%, ۱۶%, and ۲۰.۴۷% with IMOD™. Apoptosis and necrosis decreased significantly in the IMOD™ treated groups (P<۰.۰۵).Conclusion: IMOD™ may protect these cells against ionizing radiation.

صفحه اختصاصی مقاله و دریافت فایل کامل: https://civilica.com/doc/1819287/